Concert Pharmaceuticals

Breakthrough Alopecia Drug Can Regrow An Entire Head of Hair, Study Shows

Oral Medicine CTP-543 Shows Promising Results to Treat Mild to Severe Alopecia After Completing Phase 3 Clinical Trial

Medicine & Technology May 27, 2022

Lexington-based Concert Pharmaceuticals claims that an experimental treatment for alopecia could restore hair in up to 42% of people with severe hair loss. Read on to learn more.

Concert Pharmaceuticals

Oral Medicine CTP-543 Shows Promising Results to Treat Mild to Severe Alopecia After Completing Phase 3 Clinical Trial

Most Popular

Worst ‘Cannibal’ Solar Storm in 165 Years Expected to Crash Into Earth’s Atmosphere Tonight Causing GPS, Power Outages

Cave of Death in Costa Rica Appears Harmless but Can Instantly Kill Anyone at the Entrance

Massive X8.7 Solar Flare From Super-Active Sunspot Causes Radio Blackouts Over North, South America Days After Widespread Aurora Displays

North America Suffers Radio Blackout After a Big X-Flare on Tuesday

Kinetic Magnetism: Quantum Motion of Atom Gives Rise to New Mechanism for Attraction and Repulsion

Recommended Stories

Helium Leak Delays Boeing’s Astronaut Launch Attempt for the Second Time; Crew Debut Set on May 21 After Spacecraft Repair

Bizarre Planet 'WASP-193b' Found To Have the Density of Cotton Candy Despite Its Enormous Size, Making It Second-Least Dense Exoplanet Ever Discovered

US Space Force Orders $414M Advanced Missile Defense Satellites To Track Hypersonic Threats

SpaceX’s Starship Megarocket Prepares for Next Test Flight in 3–5 Weeks, Confirms Elon Musk